FDA Approves Poteligeo for Rare Types of Non - Hodgkin Lymphoma

Drug approved to treat relapsed or refractory mycosis fungoides and Sézary syndrome
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Oncology, Pharmacy, Institutional, Source Type: news